Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Hydroxyzine (Atarax, Vistaril) can be prescribed either on a fixed daily schedule or strictly as needed, and clinicians most often use it as needed for anxiety because it starts working within about 15 to 30 minutes and is generally intended for short-term relief. Daily use is possible under medical supervision, but sedation, dry mouth, tolerance to its calming effect, dose-related heart rhythm (QT) concerns, and extra caution for older adults, pregnancy, and liver or kidney issues all shape whether a standing dose is appropriate. Because hydroxyzine does not address the underlying drivers of ongoing anxiety, long-term reliance on it alone is usually not the goal. There are several important factors to consider, and the complete answer below explains when daily dosing makes sense, when as-needed is safer, how to stop without rebound anxiety, and the warning signs that warrant a call to your prescriber.
If your anxiety has you reaching for medication more often than expected, a free, instant, online symptom check takes only a few minut
Hydroxyzine is an antihistamine that’s often prescribed off-label for anxiety. You might recognize it under brand names like Atarax or Vistaril. Unlike benzodiazepines, hydroxyzine doesn’t carry the same risk of dependence, but it’s important to understand how and when to use it safely.
Many healthcare providers recommend hydroxyzine on an as-needed basis, especially for:
Benefits of PRN dosing:
In some cases, a physician may prescribe hydroxyzine daily for generalized anxiety disorder (GAD) if:
Points to consider:
Most side effects are mild and temporary, but you should be aware of:
In addition to hydroxyzine, consider combining these approaches:
If your anxiety worsens or you experience severe side effects (e.g., fast heartbeat, confusion, fainting), contact your healthcare provider immediately.
If you’re unsure whether your symptoms are due to anxiety, another medical condition, or medication side effects, you might try a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you decide the next best steps and whether to seek urgent care.
Remember, this information is educational and not a substitute for medical advice. If your symptoms are severe, worsening, or you have thoughts of harming yourself or others, please seek immediate medical attention or call emergency services. For any life-threatening or serious concerns, speak to a doctor right away.
(References)
* Hoss D, Segal S. Scalp dysesthesia. Arch Dermatol. 1998 Mar;134(3):327-30. doi: 10.1001/archderm.134.3.327. PMID: 9521031.
* Wellington K, Jarvis B. Cetirizine/pseudoephedrine. Drugs. 2001;61(15):2231-40; discussion 2241-2. doi: 10.2165/00003495-200161150-00009. PMID: 11772135.
* Paterson NE, Darby WC, Sandhu PS. N,N-Dimethyltryptamine-Induced Psychosis. Clin Neuropharmacol. 2015 Jul-Aug;38(4):141-3. doi: 10.1097/WNF.0000000000000078. PMID: 26166234.
* Ashley PF, Chaudhary M, Lourenço-Matharu L. Sedation of children undergoing dental treatment. Cochrane Database Syst Rev. 2018 Dec 17;12(12):CD003877. doi: 10.1002/14651858.CD003877.pub5. Epub 2018 Dec 17. PMID: 30566228; PMCID: PMC6517004.
* Hydroxyzine. 2012. PMID: 31643458.
* Garakani A, Murrough JW, Freire RC, Thom RP, Larkin K, Buono FD, Iosifescu DV. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Front Psychiatry. 2020;11:595584. doi: 10.3389/fpsyt.2020.595584. Epub 2020 Dec 23. PMID: 33424664; PMCID: PMC7786299.
* Ziffra M. Panic disorder: A review of treatment options. Ann Clin Psychiatry. 2021 May;33(2):124-133. doi: 10.127788/acp.0014. PMID: 33529291.
* Bajor LA, Balsara C, Osser DN. An evidence-based approach to psychopharmacology for posttraumatic stress disorder (PTSD) - 2022 update. Psychiatry Res. 2022 Nov;317:114840. doi: 10.1016/j.psychres.2022.114840. Epub 2022 Sep 9. PMID: 36162349.
* Drugs for anxiety disorders. Med Lett Drugs Ther. 2023 Aug 7;65(1682):121-128. doi: 10.58347/tml.2023.1682a. PMID: 37516898.
* Beenen KT, Vosters JA, Patel DR. Sport-related performance anxiety in young athletes: a clinical practice review. Transl Pediatr. 2025 Jan 24;14(1):127-138. doi: 10.21037/tp-24-258. Epub 2025 Jan 21. PMID: 39944878; PMCID: PMC11811592.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.